on HYBRIGENICS (EPA:ALHYG)
Hadrien Lanvin Appointed Deputy CEO of Aton Group
Aton Group has announced the appointment of Hadrien Lanvin as Deputy CEO. A leader in life sciences and medical technology, Aton hopes to leverage Lanvin's extensive expertise to enhance its asset portfolio. Lanvin, an HEC Paris alumnus and CEO of Evora Biosciences, joined Aton's Board of Directors in December 2023. He possesses significant knowledge of the group's portfolio and market dynamics.
In his new executive role, Lanvin aims to maximize the valuation of Aton's assets. He will focus on refining the group's strategic positioning and growth prospects. His responsibilities include boosting Aton's visibility in financial and industrial ecosystems. Chairwoman and CEO Léone Atayi expressed confidence in Lanvin's abilities to drive the company's growth at this critical juncture.
This leadership change aligns with Aton's strategic roadmap and highlights its commitment to transparent communication with the financial community.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all HYBRIGENICS news